AAAAAA
Results: 1-25/34
Authors:
Naber, KG
Wagenlehner, FME
Citation: Kg. Naber et Fme. Wagenlehner, Urinary tract infection - Diagnosis, DEUT MED WO, 126(40), 2001, pp. 1105-1105
Authors:
Wagenlehner, FME
Naber, KG
Citation: Fme. Wagenlehner et Kg. Naber, Urinary tract infection - Case report, DEUT MED WO, 126(40), 2001, pp. 1105-1108
Authors:
Wagenlehner, FME
Naber, KG
Citation: Fme. Wagenlehner et Kg. Naber, Urinary tract infection - Treatment, DEUT MED WO, 126(40), 2001, pp. 1109-1111
Authors:
Naber, KG
Citation: Kg. Naber, Prostatitis, NEPH DIAL T, 16, 2001, pp. 132-134
Authors:
Onda, H
Wagenlehner, FME
Lehn, N
Naber, KG
Citation: H. Onda et al., In vitro activity of linezolid against Gram-positive uropathogens of hospitalized patients with complicated urinary tract infections, INT J ANT A, 18(3), 2001, pp. 263-266
Authors:
Williams, JD
Naber, KG
Bryskier, A
Hoiby, N
Gould, IM
Periti, P
Giamarellou, H
Rouveix, B
Citation: Jd. Williams et al., Classification of oral cephalosporins. A matter for debate, INT J ANT A, 17(6), 2001, pp. 443-450
Authors:
Naber, KG
Citation: Kg. Naber, Urinary Tract Infection - Proceedings of the 6(th) International Symposiumon Clinical Evaluation of Drug Efficacy in Urinary Tract Infection and "Current Issues in the Management of UTI" Symposium of the Commission for Treatment of Urinary Tract Infection of the International Society of Chemotherapy held during the 21(st) International Congress of Chemotherapy - 4 July-7July 1999 in Birmingham, UK - Preface, INT J ANT A, 17(4), 2001, pp. 243-243
Authors:
Naber, KG
Hofstetter, AG
Bruhl, P
Bichler, KH
Lebert, C
Citation: Kg. Naber et al., Guidelines for the perioperative prophylaxis in urological interventions of the urinary and male genital tract, INT J ANT A, 17(4), 2001, pp. 321-326
Authors:
Naber, KG
Citation: Kg. Naber, Which fluoroquinolones are suitable for the treatment of urinary tract infections?, INT J ANT A, 17(4), 2001, pp. 331-341
Authors:
Ronald, AR
Nicolle, LE
Stamm, E
Krieger, J
Warren, J
Schaeffer, A
Naber, KG
Hooton, TM
Johnson, J
Chambers, S
Andriole, V
Citation: Ar. Ronald et al., Urinary tract infection in adults: research priorities and strategies, INT J ANT A, 17(4), 2001, pp. 343-348
Authors:
Farker, K
Naber, KG
Funfstuck, R
Citation: K. Farker et al., Fluoroquinolones: Treatment of urinary tract infections, MED KLIN, 96(7), 2001, pp. 383-390
Authors:
Wagenlehner, FME
Naber, KG
Citation: Fme. Wagenlehner et Kg. Naber, Therapy of prostatitis syndrome, UROLOGE A, 40(1), 2001, pp. 24-28
Authors:
Naber, KG
Citation: Kg. Naber, Bacterial adhesion to urethral catheters: Role of coating materials and immersion in antibiotic solution - Editorial comment, EUR UROL, 40(3), 2001, pp. 359-359
Authors:
Naber, CK
Hammer, M
Kinzig-Schippers, M
Sauber, C
Sorgel, F
Bygate, EA
Fairless, AJ
Machka, K
Naber, KG
Citation: Ck. Naber et al., Urinary excretion and bactericidal activities of gemifloxacin and ofloxacin after a single oral dose in healthy volunteers, ANTIM AG CH, 45(12), 2001, pp. 3524-3530
Authors:
Naber, CK
Steghafner, M
Kinzig-Schippers, M
Sauber, C
Sorgel, F
Stahlberg, HJ
Naber, KG
Citation: Ck. Naber et al., Concentrations of gatifloxacin in plasma and urine and penetration into prostatic and seminal fluid, ejaculate, and sperm cells after single oral administrations of 400 milligrams to volunteers, ANTIM AG CH, 45(1), 2001, pp. 293-297
Authors:
Raz, R
Naber, KG
Raizenberg, C
Rohana, Y
Unamba-Oparah, I
Korfman, G
Yaniv, I
Citation: R. Raz et al., Ciprofloxacin 250 mg twice daily versus ofloxacin 200 mg twice daily in the treatment of complicated urinary tract infections in women, EUR J CL M, 19(5), 2000, pp. 327-331
Authors:
Naber, KG
Hollauer, K
Kirchbauer, D
Witte, W
Citation: Kg. Naber et al., In vitro activity of gatifloxacin compared with gemifloxacin, moxifloxacin, trovafloxacin, ciprofloxacin and ofloxacin against uropathogens cultured from patients with complicated urinary tract infections, INT J ANT A, 16(3), 2000, pp. 239-243
Authors:
Melekos, MD
Naber, KG
Citation: Md. Melekos et Kg. Naber, Complicated urinary tract infections, INT J ANT A, 15(4), 2000, pp. 247-256
Authors:
Wagenlehner, F
Stower-Hoffmann, J
Schneider-Brachert, W
Naber, KG
Lehn, N
Citation: F. Wagenlehner et al., Influence of a prophylactic single dose of ciprofloxacin on the level of resistance of Escherichia coli to fluoroquinolones in urology, INT J ANT A, 15(3), 2000, pp. 207-211
Authors:
Naber, KG
Busch, W
Focht, J
Citation: Kg. Naber et al., Ciprofloxacin in the treatment of chronic bacterial prostatitis: a prospective, non-comparative multicentre clinical trial with long-term follow-up, INT J ANT A, 14(2), 2000, pp. 143-149
Authors:
Naber, KG
Weidner, W
Citation: Kg. Naber et W. Weidner, Chronic prostatitis - an infectious disease?, J ANTIMICRO, 46(2), 2000, pp. 157-161
Authors:
Naber, KG
Citation: Kg. Naber, Treatment options for acute uncomplicated cystitis in adults, J ANTIMICRO, 46, 2000, pp. 23-27
Authors:
Naber, KG
Citation: Kg. Naber, Survey on antibiotic usage in the treatment of urinary tract infections, J ANTIMICRO, 46, 2000, pp. 49-52
Authors:
Wise, R
Jarlier, V
Naber, KG
Graninger, W
Nicolle, LE
Hooton, T
Cars, O
Hoiby, N
Bint, AJ
Mandell, L",Khalmeter,"Brown, EM
Citation: R. Wise et al., Progress in the management of urinary tract infections: discussion, J ANTIMICRO, 46, 2000, pp. 63-65
Authors:
Wagenlehner, FME
Naber, KG
Citation: Fme. Wagenlehner et Kg. Naber, Hospital-acquired urinary tract infections, J HOSP INF, 46(3), 2000, pp. 171-181